Cargando…
Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the hematopoietic system and has been treated with the drug Imatinib relatively successfully. Drug resistance, acquired by mutations, is an obstacle to success. Two additional drugs are now considered and could be combined with Imatinib to prevent resist...
Autores principales: | Komarova, Natalia L., Katouli, Allen A., Wodarz, Dominik |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635955/ https://www.ncbi.nlm.nih.gov/pubmed/19204794 http://dx.doi.org/10.1371/journal.pone.0004423 |
Ejemplares similares
-
Optimizing Combination Therapies with Existing and Future CML Drugs
por: Katouli, Allen A., et al.
Publicado: (2010) -
Synaptic transmission and the susceptibility of HIV infection to anti-viral drugs
por: Komarova, Natalia L., et al.
Publicado: (2013) -
Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection
por: Wodarz, Dominik, et al.
Publicado: (2009) -
Effect of Cellular Quiescence on the Success of Targeted CML Therapy
por: Komarova, Natalia L., et al.
Publicado: (2007) -
Targeted cancer treatment in silico: small molecule inhibitors and oncolytic viruses
por: Komarova, Natalia L, et al.
Publicado: (2014)